Interventions to prevent HIV and Hepatitis C in people who inject drugs: A review of reviews to assess evidence of effectiveness
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abbott, 1998, AIDS risk behavior in opioid dependent patients treated with community reinforcement approach and relationships with psychiatric disorders, Journal of Addictive Diseases, 17, 33, 10.1300/J069v17n04_04
Avants, 1998, When is less treatment better?. The role of social anxiety in matching methadone patients to psychosocial treatments, Journal of Consulting & Clinical Psychology, 66, 924, 10.1037/0022-006X.66.6.924
Avants, 1999, Day treatment versus enhanced standard methadone services for opioid-dependent patients: A comparison of clinical efficacy and cost, American Journal of Psychiatry, 156, 27, 10.1176/ajp.156.1.27
Avants, 2004, Targeting HIV-related outcomes with intravenous drug users maintained on methadone: A randomized clinical trial of a harm reduction group therapy, Journal of Substance Abuse Treatment, 26, 67, 10.1016/S0740-5472(03)00159-4
Baker, 1993, Evaluation of a cognitive-behavioural intervention for HIV prevention among injecting drug users, AIDS, 7, 247, 10.1097/00002030-199302000-00014
Baker, 1995, HIV risk-taking behaviour among injecting drug users currently, previously and never enrolled in methadone treatment, Addiction, 90, 545, 10.1111/j.1360-0443.1995.tb02189.x
Ball, 1998, HIV prevention among injecting drug users: Responses in developing and transitional countries. [Review] [63 refs], Public Health Reports, 113
Bastos, 2000, Evaluating effectiveness of syringe exchange programmes: Current issues and future prospects, Social Science & Medicine, 51, 1771, 10.1016/S0277-9536(00)00109-X
Batki, 1989, HIV-infected i.v. drug users in methadone treatment: Outcome and psychological correlates—a preliminary report, NIDA Research Monograph, 95, 406
Bell, 1997, Occupational risk of human immunodeficiency virus infection in healthcare workers: An overview, American Journal of Medicine, 102, 9, 10.1016/S0002-9343(97)89441-7
Benninghoff, 2002, Résultats de l’étude de la clientèle de Cactus BIEL/BIENNE 2001, Lausanne: Institut universitaire de médecine sociale et préventive
Benninghoff, 2003, Evaluation de Quai 9 “Espace d’accueil et d’injection” à Genève; periode 12/2001-12/2000, Lausanne; Institut universitaire de médicine sociale et préventive
Bluthenthal, 1998, Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland California, 1992 to 1995, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, 505, 10.1097/00042560-199808150-00013
Bluthenthal, 2000, The effect of syringe exchange use on high-risk injection drug users: A cohort study, AIDS, 14, 605, 10.1097/00002030-200003310-00015
Bluthenthal, 2004, Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities, Addiction, 99, 1136, 10.1111/j.1360-0443.2004.00694.x
Broadhead, 1998, Harnessing peer networks as an instrument for AIDS prevention: Results from a peer-driven intervention, Public Health Reports, 113
Broadhead, 1999, The impact of a needle exchange's closure, Public Health Reports, 114, 439, 10.1093/phr/114.5.439
Broadhead, 2006, Peer-driven HIV interventions for drug injectors in Russia: First year impact results of a field experiment, International Journal of Drug Policy, 17, 379, 10.1016/j.drugpo.2006.06.001
Brooner, 1998, Drug abuse treatment success among needle exchange participants, Public Health Reports, 113
Bruneau, 1997, Assessing harm reduction strategies: The dilemma of observational studies, American Journal of Epidemiology, 146, 1007, 10.1093/oxfordjournals.aje.a009228
Bruneau, 1997, High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: Results of a cohort study, American Journal of Epidemiology, 146, 994, 10.1093/oxfordjournals.aje.a009240
Calsyn, 1991, Needle-use practices among intravenous drug users in an area where needle purchase is legal, AIDS, 5, 187, 10.1097/00002030-199102000-00009
Calsyn, 1992, Ineffectiveness of AIDS education and HIV antibody testing in reducing high-risk behaviors among injection drug users, American Journal of Public Health, 82, 573, 10.2105/AJPH.82.4.573
Camacho, 1996, Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance, Drug & Alcohol Dependence, 41, 1, 10.1016/0376-8716(96)01235-5
Caplehorn, 1995, Methadone maintenance and the likelihood of risky needle-sharing, International Journal of the Addictions, 30, 685, 10.3109/10826089509048753
Castro, 1997, Treatment issues with Latinos addicted to cocaine and heroin, 191
Chamot, 1992, Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone-maintenance programme, AIDS, 6, 430, 10.1097/00002030-199204000-00013
Chatham, 1999, Gender differences at admission and follow-up in a sample of methadone maintenance clients, Substance Use & Misuse, 34, 1137, 10.3109/10826089909039401
Chen, 2005, A pilot study of the NGO-based relational intervention model for HIV prevention among drug users in China, AIDS Education & Prevention, 17, 503, 10.1521/aeap.2005.17.6.503
Colon, 2009, Pilot trial of an intervention aimed at modifying drug preparation practices among injection drug users in Puerto Rico, AIDS and Behavior, 13, 523, 10.1007/s10461-009-9540-3
Colon, 1993, Effects of a HIV risk reduction education program among injection drug users in Puerto Rico, Puerto Rico Health Sciences Journal, 12, 27
Colon, 1995, Effects of a community outreach program in HIV risk behaviors among injection drug users in San Juan, Puerto Rico: An analysis of trends, AIDS Education & Prevention, 7, 195
Cooper, 2011, Spatial access to syringe exchange programs and pharmacies selling over the counter syringes as predictors of drug injectors’ use of sterile syringes, American Journal of Epidemiology, 101, 1118
Copenhaver, 2006, Behavioral HIV risk reduction among people who inject drugs: Meta-analytic evidence of efficacy, The Journal of Substance Abuse Treatment, 31, 163, 10.1016/j.jsat.2006.04.002
Cox, 2000, Syringe exchanges: A public health response to problem drug use, Irish Medical Journal, 93, 143
Coyle, 1998, Outreach-based HIV prevention for injecting drug users: A review of published outcome data, Public Health Reports, 113, 19
Craine, 2010, Characteristics of injecting drug users accessing different types of needle and syringe programme or using secondary distribution, Journal of Public Health, 32, 328, 10.1093/pubmed/fdp131
Craine, 2009, Incidence of hepatitis C in drug injectors: The role of homelessness, opiate substitution treatment, equipment sharing, and community size, Epidemiology & Infection, 137, 1255, 10.1017/S095026880900212X
Crofts, 1997, Methadone maintenance and hepatitis C virus infection among injecting drug users, Addiction, 92, 999, 10.1111/j.1360-0443.1997.tb02979.x
De Jong, 1999, Rapid assessment of injection drug use and HIV in the Republic of Georgia, Journal of Drug Issues, 29, 843, 10.1177/002204269902900406
Degenhardt, 2010, Prevention of HIV infection for people who inject drugs: Why individual, structural, and combination approaches are needed, The Lancet, 376, 285, 10.1016/S0140-6736(10)60742-8
Deren, 1995, Outcomes of a risk-reduction intervention with high-risk populations: The Harlem Aids Project, AIDS Education and Prevention, 7, 379
Des Jarlais, 2000, Behavioral risk reduction in a declining HIV epidemic: Injection drug users in New York City, 1990-1997, American Journal of Public Health, 90, 1112, 10.2105/AJPH.90.7.1112
Des Jarlais, 1998, Preventing epidemics of HIV-1 among injecting drug users
Des Jarlais, 1994, Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992, JAMA, 271, 121, 10.1001/jama.271.2.121
Des Jarlais, 1995, Maintaining low HIV seroprevalence in populations of injecting drug users, JAMA, 274, 1226, 10.1001/jama.1995.03530150050033
Des Jarlais, 2005, Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001, AIDS, 19, S20, 10.1097/01.aids.0000192066.86410.8c
Dolan, 2000, Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia, Drug and Alcohol Review, 19, 337, 10.1080/713659379
Dolan, 2003, A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system, Drug and Alcohol Dependence, 72, 59, 10.1016/S0376-8716(03)00187-X
Donoghoe, 1992, Life-style factors and social circumstances of syringe sharing in injecting drug users, British Journal of Addiction, 87, 993, 10.1111/j.1360-0443.1992.tb03116.x
Donoghoe, 1989, Changes in HIV risk behaviour in clients of syringe-exchange schemes in England and Scotland, AIDS, 3, 267, 10.1097/00002030-198905000-00003
Ellis, 2003
European Centre for Disease Prevention and Control and European Monitoring Centre for Drugs and Drug Addiction, 2011
Fisher, 2003, Needle exchange and injection drug use frequency: A randomized clinical trial, Journal of Acquired Immune Deficiency Syndromes, 33, 199, 10.1097/00126334-200306010-00014
Frischer, 1993, Discriminating needle exchange attenders from non-attenders, Addiction, 88, 681, 10.1111/j.1360-0443.1993.tb02081.x
Gerberding, 1995, Management of occupational exposures to blood-borne viruses, New England Journal of Medicine, 332, 444, 10.1056/NEJM199502163320707
Gibson, 2002, Two- to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange, Journal of Acquired Immune Deficiency Syndromes, 31, 237, 10.1097/00126334-200210010-00015
Gibson, 2001, Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users, AIDS, 15, 1329, 10.1097/00002030-200107270-00002
Gibson, 1999, Effectiveness of brief counseling in reducing HIV risk behavior in injecting drug users: Final results of randomized trials of counseling with and without HIV testing, AIDS and Behavior, 3, 3, 10.1023/A:1025409801012
Gillies, 2010, The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: A systematic review, BMC Public Health, 2010/11/26, 721, 10.1186/1471-2458-10-721
Gleghorn, 1995, Acquisition and use of needles and syringes by injecting drug users in Baltimore, Maryland, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 10, 97, 10.1097/00042560-199509000-00014
Gleghorn, 1998, Feasibility of one-time use of sterile syringes: A study of active injection drug users in seven United States metropolitan areas, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, S30, 10.1097/00042560-199802001-00007
Goldberg, 2001, Trends in HCV prevalence among injecting drug users in Glasgow and Edinburgh during the era of needle/syringe exchange, Scandinavian Journal of Infectious Diseases, 33, 457, 10.1080/00365540152029936
Goldberg, 1998, Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high, Communicable Disease and Public Health, 1, 95
Gossop, 2000, Patterns of improvement after methadone treatment: 1 year follow-up results from the National Treatment Outcome Research Study, Drug and Alcohol Dependence, 60, 275, 10.1016/S0376-8716(00)00109-5
Gowing, 2008, Substitution treatment of injecting opioid users for prevention of HIV infection. [Review] [120 refs] [Update of Cochrane Database Syst Rev. 2004; (4):CD004145; PMID: 15495080], Cochrane Database of Systematic Reviews, CD004145
Green, 2010, Prevalence and predictors of transitions to and away from syringe exchange use over time in 3 US cities with varied syringe dispensing policies, Drug and Alcohol Dependence, 111, 74, 10.1016/j.drugalcdep.2010.03.022
Greenfield, 1995, Validity of intravenous drug abusers’ self-reportd changes in HIV high-risk drug use behaviors, Drug and Alcohol Dependence, 39, 91, 10.1016/0376-8716(95)01155-R
Grella, 1996, What happens when a demonstration project ends. Consequences for a clinic and its clients, Journal of Substance Abuse, 13, 249, 10.1016/S0740-5472(96)00055-4
Groseclose, 1995, Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers—Connecticut, 1992-1993, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 10, 82, 10.1097/00042560-199509000-00012
Guydish, 1998, Evaluating needle exchange: A description of client characteristics, health status, program utilization, and HIV risk behavior, Substance Use & Misuse, 33, 1173, 10.3109/10826089809062213
Guydish, 1995, Evaluation of needle exchange using street-based survey methods, Journal of Drug Issues, 25, 33, 10.1177/002204269502500103
Hagan, 1994
Hagan, 1993, An interview study of participants in the Tacoma, Washington, syringe exchange, Addiction, 88, 1691, 10.1111/j.1360-0443.1993.tb02044.x
Hagan, 1995, Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program, American Journal of Public Health, 85, 1531, 10.2105/AJPH.85.11.1531
Hagan, 1999, Syringe exchange and risk of infection with hepatitis B and C viruses, American Journal of Epidemiology, 149, 203, 10.1093/oxfordjournals.aje.a009792
Hagan, 2011, A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs, Journal of Infectious Disease, 204, 74, 10.1093/infdis/jir196
Hagan, 2000, Changes in injection risk behavior associated with participation in the Seattle needle-exchange program, Journal of Urban Health, 77, 369, 10.1007/BF02386747
Hallinan, 2004, Hepatitis C virus incidence among injecting drug users on opioid replacement therapy, Australian and New Zealand Journal of Public Health, 28, 576, 10.1111/j.1467-842X.2004.tb00050.x
Hammett, 2006, Patterns of HIV prevalence and HIV risk behaviors among injection drug users prior to and 24 months following implementation of cross-border HIV prevention interventions in northern Vietnam and southern China, AIDS Education and Prevention, 18, 97, 10.1521/aeap.2006.18.2.97
Hart, 1989, Evaluation of needle exchange in central London: Behaviour change and anti-HIV status over one year, AIDS, 3, 261, 10.1097/00002030-198905000-00002
Hartel, 1998, Methadone treatment protects against HIV infection: Two decades of experience in the Bronx, New York City, Public Health Reports, 113, 107
Hartgers, 1989, The impact of the needle and syringe-exchange programme in Amsterdam on injecting risk behaviour, AIDS, 3, 571, 10.1097/00002030-198909000-00003
Hartgers, 1992, Needle sharing and participation in the Amsterdam Syringe Exchange program among HIV-seronegative injecting drug users, Public Health Reports, 107, 675
Hedrich, 2004
Heimer, 2002, Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities, Addiction, 97, 1277, 10.1046/j.1360-0443.2002.t01-1-00211.x
Heimer, 1998, Syringe use and reuse: Effects of syringe exchange programs in four cities, Journal of Acquired Immune Deficiency Syndromes, 1998/07/15, S37, 10.1097/00042560-199802001-00008
Heinemann, 2001, Prevention of blood-brone virus infections among drug users in an open prison by syringe vending machines, Sucht, 47, 57, 10.1024/suc.2001.47.1.57
Herbst, 2007, A systematic review and meta-analysis of behavioral interventions to reduce HIV risk behaviors of hispanics in the United States and Puerto Rico, AIDS & Behavior, 11, 25, 10.1007/s10461-006-9151-1
Hernandez-Aguado, 2001, Measures to reduce HIV infection have not been successful to reduce the prevalence of HCV in intravenous drug users, European Journal of Epidemiology, 17, 539, 10.1023/A:1014560431726
Holtzman, 2009, The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004, Preventive Medicine, 49, 68, 10.1016/j.ypmed.2009.04.014
Hong, 2009, HIV/AIDS behavioral interventions in China: A literature review and recommendation for future research, AIDS and Behavior, 13, 603, 10.1007/s10461-008-9483-0
Hunter, 1995, Changes in the injecting risk behaviour of injecting drug users in London, 1990-1993, AIDS, 9, 493, 10.1097/00002030-199509050-00012
Huo, 2005, Changes in the sharing of drug injection equipment among street-recruited injection drug users in Chicago, Illinois, 1994–1996, Substance Use & Misuse, 40, 63, 10.1081/JA-200030495
Huo, 2007, Needle exchange and injection-related risk behaviors in Chicago: A longitudinal study, Journal of Acquired Immune Deficiency Syndromes, 45, 108, 10.1097/QAI.0b013e318050d260
Hutchinson, 2002, Prevalence of hepatitis C among injectors in Scotland 1989-2000: Declining trends among young injectors halt in the late, Epidemiology and Infection, 128, 473, 10.1017/S0950268802006945
Iguchi, 1998, Drug abuse treatment as HIV prevention: Changes in social drug use patterns might also reduce risk, Journal of Addictive Diseases, 17, 9, 10.1300/J069v17n04_02
Ingold, 1989, The effects of the liberalisation of syringe sales on the behaviour of intravenous drug users in France, Bulletin of Narcotics, 1, 67
Islam, 2008, Client satisfaction and risk behaviours of the users of syringe dispensing machines: A pilot study, Drug and Alcohol Reviews, 27, 13, 10.1080/09595230701711199
Islam, 2008, The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings, International Journal of Drug Policy, 19, 436, 10.1016/j.drugpo.2007.07.006
Islam, 2007, Assessing the role of syringe dispensing machines and mobile van outlets in reaching hard-to-reach and high-risk groups of injecting drug users (IDUs): A review, Harm Reduction Journal, 4, 14, 10.1186/1477-7517-4-14
Jones, 2010, Optimal provision of needle and syringe programmes for injecting drug users: A systematic review, International Journal of Drug Policy, 21, 335, 10.1016/j.drugpo.2010.02.001
Keene, 1993, Evaluation of syringe-exchange for HIV prevention among injecting drug users in rural and urban areas of Wales, Addiction, 88, 1063, 10.1111/j.1360-0443.1993.tb02125.x
Kelly, 2002
Kerr, 2007, The role of safer injection facilities in the response to HIV/AIDS among injection drug users, Current HIV/AIDS Reports, 4, 158, 10.1007/s11904-007-0023-8
Kerr, 2005, Safer injection facility use and syringe sharing in injection drug users, Lancet, 366, 316, 10.1016/S0140-6736(05)66475-6
Khoshnood, 2000, Syringe source, use, and discard among injection-drug users in New Haven, Connecticut, AIDS Public Policy Journal, 15, 88
Kimber, 2003, Drug consumption facilities: An update since 2000, Drug and Alcohol Review, 22, 227, 10.1080/095952301000116951
Kimber, 2010, Harm reduction among injecting drug users—Evidence of effectiveness, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 115–163
King, 2000, Influence of psychiatric comorbidity on HIV risk behaviors: Changes during drug abuse treatment, Journal of Addictive Diseases, 19, 65, 10.1300/J069v19n04_07
Kipke, 1997, Drug injecting street youth: A comparison of HIV risk-injection behaviors between needle exchange users and non-users, AIDS and Behaviour, 1, 225, 10.1023/A:1026275301883
Klee, 1991, The sharing of injecting equipment among drug users attending prescribing clinics and those using needle-exchanges, British Journal of Addiction, 86, 217, 10.1111/j.1360-0443.1991.tb01771.x
Klee, 1995, The role of needle exchanges in modifying sharing behaviour: Cross-study comparisons 1989-1993, Addiction, 90, 1635, 10.1111/j.1360-0443.1995.tb02834.x
Kretzschmar, 1998, Modelling the spread of HIV in social networks of injecting drug users, AIDS, 12, 801, 10.1097/00002030-199807000-00017
Kumar, 1998, Community-based outreach HIV intervention for street-recruited drug users in Madras, India, Public Health Reports, 113
Kwiatkowski, 2001, Methadone maintenance as HIV risk reduction with street-recruited injecting drug users, Journal of Acquired Immune Deficiency Syndromes: JAIDS, 26, 483, 10.1097/00126334-200104150-00014
Lamden, 1998, Hepatitis B and hepatitis C virus infections: Risk factors among drug users in Northwest England, Journal of Infection, 37, 260, 10.1016/S0163-4453(98)92045-X
Latkin, 1998, Outreach in natural settings: The use of peer leaders for HIV prevention among injecting drug users’ networks, Public Health Reports, 113
Latkin, 2003, HIV prevention among drug users: Outcome of a network-oriented peer outreach intervention, Health Psychology, 22, 339, 10.1037/0278-6133.22.4.332
Li, 2001, Evaluation on peer education program among injecting drug users, Zhonghua Liu Xing Bing Xue Za Zhi, 22, 334
Longshore, 2001, Needle exchange program attendance and injection risk in Providence Rhode Island, AIDS Education and Prevention, 13, 78, 10.1521/aeap.13.1.78.18922
Longshore, 1993, Methadone maintenance and needle/syringe sharing, International Journal of the Addictions, 28, 983, 10.3109/10826089309062178
Lott, 2006, HIV risk behaviors during pharmacologic treatment for opioid dependence: A comparison of levomethadyl acetate hydrochloride, buprenorphine, and methadone: “Erratum”, Journal of Substance Abuse Treatment, 31, 317
MacArthur, 2011
MacDonald, 2000, Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997. Collaboration of Australian NSPs, Medical Journal, 172, 57
Magura, 1998, Temporal patterns of heroin and cocaine use among methadone patients, Substance Use and Misuse, 33, 2441, 10.3109/10826089809059334
Magura, 1991, Outcomes of an AIDS prevention program for methadone patients, International Journal of the Addictions, 26, 629, 10.3109/10826089109058910
Maher, 2006, Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia, Addiction, 101, 1499, 10.1111/j.1360-0443.2006.01543.x
Mandell, 1994, Changes in HIV risk behaviors among counseled injecting drug users, Journal of Drug Issues, 24, 555, 10.1177/002204269402400314
Mansson, 2000, Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program, Scandinavian Journal of Infectious Diseases, 32, 253, 10.1080/00365540050165875
Margolin, 2003, A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users, Health Psychology, 22, 223, 10.1037/0278-6133.22.2.223
Mark, 2006, Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs, Public Health Nursing, 23, 11, 10.1111/j.0737-1209.2006.230103.x
Marsch, 2005, Buprenorphine treatment for opioid dependence: The relative efficacy of daily, twice and thrice weekly dosing, Drug & Alcohol Dependence, 77, 195, 10.1016/j.drugalcdep.2004.08.011
Mathers, 2010, HIV prevention, treatment, and care services for people who inject drugs: A systematic review of global, regional, and national coverage, Lancet, 375, 1014, 10.1016/S0140-6736(10)60232-2
Mathers, 2008, Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. [Review] [22 refs], Lancet, 372, 1733, 10.1016/S0140-6736(08)61311-2
Meandzija, 1994, HIV infection and cocaine use in methadone maintained and untreated intravenous drug users, Drug & Alcohol Dependence, 36, 109, 10.1016/0376-8716(94)90092-2
Medley, 2009, Effectiveness of peer education interventions for HIV prevention in developing countries: A systematic review and meta-analysis, AIDS Education and Prevention, 21, 181, 10.1521/aeap.2009.21.3.181
Metzger, 1993, Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up, Journal of Acquired Immune Deficiency Syndromes, 6, 1049
Miller, 2002, HIV incidence and associated risk factors among young injection drug users, AIDS, 16, 491, 10.1097/00002030-200202150-00025
Miller, 2002, Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges, Journal of Urban Health, 79, 257, 10.1093/jurban/79.2.257
Miller, 2004, The future face of coinfection: Prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users, Journal of Acquired Immune Deficiency Syndromes: JAIDS, 36, 743, 10.1097/00126334-200406010-00012
Monterroso, 2000, Prevention of HIV infection in street-recruited injection drug users. The Collaborative Injection Drug User Study (CIDUS), Journal of Acquired Immune Deficiency Syndromes, 25, 63, 10.1097/00126334-200009010-00009
Morissette, 2007, Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: Implications for HIV and hepatitis C prevention, International Journal of Drug Policy, 18, 204, 10.1016/j.drugpo.2006.08.004
Moss, 1994, HIV seroconversion in intravenous drug users in San Francisco, 1985-1990, AIDS, 8, 223, 10.1097/00002030-199402000-00010
MSIC Evaluation Committee, 2003
Nacopoulos, 2010, Syringe exchange programs: Impact on injection drug users and the role of the pharmacist from a U.S. perspective, Journal of the American Pharmacists Association, 50, 148, 10.1331/JAPhA.2010.09178
National Institute on Drug Abuse, 1994
Navaline, 1994, An automated version of the risk assessment battery (RAB): Enhancing the assessment of risk behaviors, AIDS Research and Human Retroviruses, 10, S281
Neaigus, 1990, Effects of outreach intervention on risk reduction among intravenous drug users, AIDS Education & Prevention, 2, 253
Neaigus, 2008, Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal, Journal of Urban Health, 85, 309, 10.1007/s11524-008-9271-1
Needle, 2005, Effectiveness of community-based outreach in preventing HIV/AIDS among injecting drug users, International Journal of Drug Policy, 16, S45, 10.1016/j.drugpo.2005.02.009
Nejedly, 1996, 1996
Nelson, 1991, Human immunodeficiency virus infection in diabetic intravenous drug users, JAMA, 266, 2259, 10.1001/jama.1991.03470160091038
Nelson, 2011, Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews, The Lancet, 378, 571, 10.1016/S0140-6736(11)61097-0
Novick, 1990, Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients, Archives of Internal Medicine, 150, 97, 10.1001/archinte.1990.00390130099014
Obadia, 1999, Syringe vending machines for injection drug users: An experiment in Marseille France, American Journal of Public Health, 89, 1852, 10.2105/AJPH.89.12.1852
Oliver, 1994, Behavioral and community impact of the Portlandsyringe exchange programm, 35
Ouellet, 2004, HIV risk practices among needle exchange users and nonusers in Chicago, Journal of Acquired Immune Deficiency Syndromes, 37, 1187, 10.1097/01.qai.0000120802.43677.ea
Palmateer, 2008
Palmateer, 2010, Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: A review of reviews, Addiction, 105, 844, 10.1111/j.1360-0443.2009.02888.x
Paone, 1994, New York syringe exchange; an overview, 47
Patrick, 2001, Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection, Cmaj, 165, 889
Peak, 1995, Declining risk for HIV among injecting drug users in Kathmandu, Nepal: The impact of a harm-reduction programme, AIDS, 9, 1067, 10.1097/00002030-199509000-00013
Pouget, 2005, Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program, Journal of Acquired Immune Deficiency Syndromes, 39, 471, 10.1097/01.qai.0000152395.82885.c0
Power, 2002, The value of process evaluation in sustaining HIV harm reduction in the Russian Federation, AIDS, 16, 303, 10.1097/00002030-200201250-00028
Prendergast, 2001, Meta-analysis of HIV risk-reduction interventions within drug abuse treatment programs, Journal of Consulting & Clinical Psychology, 69, 389, 10.1037/0022-006X.69.3.389
Reyes Fuentes, 2003
Rezza, 1996, Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence, Scandinavian Journal of Infectious Disease, 28, 27, 10.3109/00365549609027145
Rhoades, 1998, Retention, HIV risk, and illicit drug use during treatment: Methadone dose and visit frequency, American Journal of Public Health, 88, 34, 10.2105/AJPH.88.1.34
Rhodes, 2004, Injecting equipment sharing among injecting drug users in Togliatti City, Russian Federation: Maximizing the protective effects of syringe distribution, Journal of Acquired Immune Deficiency Syndromes, 35, 293, 10.1097/00126334-200403010-00011
Richard, 2002, New syringe acquisition and multi-person use of syringes among illegal drug users, Journal of Public Health Policy, 23, 324, 10.2307/3343228
Robles, 1993
Robles, 2004, Effects of combined counseling and case management to reduce HIV risk behaviors among Hispanic drug injectors in Puerto Rico, Journal of Substance Abuse Treatment, 27, 145, 10.1016/j.jsat.2004.06.004
Ronco, 1996, Evaluation des ‘Aufenhalts-and Betreuungsraum für Drogenabhängige’ in Luzern, Sozial-und Präventivemedizin, 41, S45, 10.1007/BF01318588
Roy, 2006, Hepatitis C virus infection among injecting drug users in Scotland: A review of prevalence and incidence data and the methods used to generate them, Epidemiology and Infection, 135, 433, 10.1017/S0950268806007035
Ruan, 2007, Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: A 3-year follow-up study, AIDS, 21
Sacks-Davis, 2011, Behavioural interventions for preventing hepatitis C infection in people who inject drugs: A global systematic review, International Journal of Drug Policy
Sarang, 2008, Access to syringes in three Russian cities: Implications for syringe distribution and coverage, International Journal of Drug Policy, 19, S25, 10.1016/j.drugpo.2007.11.008
Sarkar, 2003, Rapid spread of hepatitis C and needle exchange programme in Kolkata India, Lancet, 361, 1301, 10.1016/S0140-6736(03)13006-1
Saxon, 1994, Longitudinal changes in injection behaviors in a cohort of injection drug users, Addiction, 89, 191, 10.1111/j.1360-0443.1994.tb00878.x
Schilling, 2000, HIV risk reduction among injection drug users: Explaining the lack of anticipated outcomes in a community-level controlled comparison study, Evaluation and Program Planning, 23, 301, 10.1016/S0149-7189(00)00016-1
Schoenbaum, 1996, Needle exchange use among a cohort of injecting drug users, AIDS, 10, 1729, 10.1097/00002030-199612000-00018
Schroeder, 2006, Changes in HIV risk behaviors among patients receiving combined pharmacological and behavioral interventions for heroin and cocaine dependence, Addictive Behaviors, 31, 868, 10.1016/j.addbeh.2005.07.009
Sears, 2001, Investigation of a secondary syringe exchange program for homeless young adult injection drug users in San Francisco, California U. S. A., Journal of Acquired Immune Deficiency Syndromes, 27, 193, 10.1097/00126334-200106010-00015
Sears, 2001, A cohort study of syringe exchangers and nonexchangers in San Francisco, Journal of Drug Issues, 13, 445, 10.1177/002204260103100205
Sees, 2000, Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: A randomized controlled trial, JAMA, 283, 1303, 10.1001/jama.283.10.1303
Selvey, 1997, Incidence and prevalence of hepatitis C among clients of a Brisbane methadone clinic: Factors influencing hepatitis C serostatus, Australian and New Zealand Journal of Public Health, 21, 102, 10.1111/j.1467-842X.1997.tb01664.x
Sergeyev, 1999, HIV prevention in Yaroslavl, Russia: A peer-driven intervention and needle exchange, Journal of Drug Issues, 29, 777, 10.1177/002204269902900403
Serpelloni, 1994, Methadone treatment as a determinant of HIV risk reduction among injecting drug users: A nested case-control study, AIDS Care, 6, 215, 10.1080/09540129408258632
Sharma, 2007, Coverage of HIV prevention programmes for injection drug users: Confusions, aspirations, definitions and ways forward, International Journal of Drug Policy, 18, 92, 10.1016/j.drugpo.2006.11.012
Shore, 1996, Methadone maintenance and other factors associated with intraindividual temporal trends in injection-drug use, Journal of Substance Abuse Treatment, 13, 248, 10.1016/S0740-5472(96)00051-7
Simpson, 1995, Client engagement and change during drug abuse treatment, Journal of Substance Abuse, 7, 117, 10.1016/0899-3289(95)90309-7
Singer, 1997, Changing the environment of AIDS risk: Findings on syringe exchange and pharmacy sales of syringes in Hartford CT, Medical Anthropology, 18, 107, 10.1080/01459740.1997.9966152
Smyth, 1999, Evaluation of the impact of Dublin's expanded harm reduction programme on prevalence of hepatitis C among short-term injecting drug users, Journal of Epidemiology and Community Health, 53, 434, 10.1136/jech.53.7.434
Somaini, 2000, A continuing concern: HIV and hepatitis testing and prevalence among drug users in substitution programmes in Zurich, Switzerland, AIDS Care, 12, 449, 10.1080/09540120050123855
Sorensen, 2000, Drug abuse treatment as an HIV prevention strategy: A review. [Review] [70 refs], Drug & Alcohol Dependence, 59, 17, 10.1016/S0376-8716(99)00104-0
Sorensen, 1994, Psychoeducational group approach: HIV risk reduction in drug users, AIDS Education & Prevention, 6, 95
Stark, 1996, Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin, Journal of Epidemiology & Community Health, 50, 534, 10.1136/jech.50.5.534
Stein, 2002, A brief intervention for hazardous drinkers in a needle exchange program, Journal of Substance Abuse Treatment, 22, 23, 10.1016/S0740-5472(01)00207-0
Sterk, 2003, HIV risk reduction among African-American women who inject drugs: A randomized controlled trial, AIDS and Behavior, 7, 73, 10.1023/A:1022565524508
Stoltz, 2007, Changes in injecting practices associated with the use of a medically supervised safer injection facility, Journal of Public Health (Oxf), 29, 35, 10.1093/pubmed/fdl090
Strang, 2000, Randomized trial of supervised injectable versus oral methadone maintenance: Report of feasibility and 6-month outcome, Addiction, 95, 1631, 10.1046/j.1360-0443.2000.951116314.x
Strathdee, 1997, Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada, Addiction, 92, 1339, 10.1111/j.1360-0443.1997.tb02852.x
Strathdee, 1997, Needle exchange is not enough: Lessons from the Vancouver injecting drug use study, AIDS, 11, F59, 10.1097/00002030-199708000-00001
Taylor, 2000, Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: Are current harm reduction strategies working?, Journal of Infection, 40, 176, 10.1053/jinf.2000.0647
Teesson, 2006, One year outcomes for heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS), Drug & Alcohol Dependence, 83, 174, 10.1016/j.drugalcdep.2005.11.009
Thiede, 2000, Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area, Journal of Urban Health, 77, 331, 10.1007/BF02386744
Tilson, 2007
Trubnikov, 2003, Sources of injecting equipment for drug users in Moscow Russia, International Journal of Drug Policy, 14, 453, 10.1016/S0955-3959(03)00145-2
Turner, 2011, The impact of needle and syringe provision and opiate substitution therapy on the incidence of Hepatitis C virus in injecting drug users: Pooling of UK evidence, Addiction, 106, 1978, 10.1111/j.1360-0443.2011.03515.x
van Ameijden, 1998, Maximum impact of HIV prevention measures targeted at injecting drug users, AIDS, 12, 625, 10.1097/00002030-199806000-00012
van Ameijden, 1994, Injecting risk behavior among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs, American Journal of Public Health, 84, 275, 10.2105/AJPH.84.2.275
van Ameijden, 1993, A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam, European Journal of Epidemiology, 9, 255, 10.1007/BF00146260
Van Den Berg, 2007, Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: Evidence from the Amsterdam Cohort Studies among drug users, Addiction, 102, 1454, 10.1111/j.1360-0443.2007.01912.x
van den Hoek, 1989, Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS, American Journal of Public Health, 79, 1355, 10.2105/AJPH.79.10.1355
Vazirian, 2005, Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran Iran: A cross-sectional study, Harm Reduction Journal, 2, 19, 10.1186/1477-7517-2-19
Vertefeuille, 2000, Decline in self-reported high-risk injection-related behaviors among HIV-seropositive participants in the Baltimore needle exchange program, AIDS and Behavior, 4, 381, 10.1023/A:1026406623736
Vickerman, 2007, Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study, International Journal of Epidemiology, 36, 396, 10.1093/ije/dyl276
Vlahov, 1997, Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 16, 400, 10.1097/00042560-199712150-00014
Voytek, 2003, A matter of convenience: Factors influencing secondary syringe exchange in Baltimore, Maryland USA, International Journal of Drug Policy, 14, 465, 10.1016/S0955-3959(03)00147-6
Ward, 1990
Watters, 1994, Syringe and needle exchange as HIV/AIDS prevention for injection drug users, JAMA, 271, 115, 10.1001/jama.1994.03510260047027
Wiebel, 1996, Risk behavior and HIV seroincidence among out-of-treatment injection drug users: A four-year prospective study, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 12, 282, 10.1097/00042560-199607000-00008
Wiessing, 2011, Trends in HIV and hepatitis c virus infections among injecting drug users in Europe. 2005-2010, Eurosurveillance, 16, 10.2807/ese.16.48.20031-en
Wiessing, 2008, HIV among injecting drug users in Europe: Increasing trends in the East, Eurosurveillance, 13, 10.2807/ese.13.50.19067-en
Williams, 1992, Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users, AIDS Care, 4, 35, 10.1080/09540129208251618
Williams, 2010, Race and distance effects on regular syringe exchange program use and injection risks: A geobehavioral analysis, American Journal of Public Health, 100, 1068, 10.2105/AJPH.2008.158337
Wodak, 2004
Wong, 2000, Estimating future hepatitis C morbidity, mortality, and costs in the United States, American Journal of Public Health, 90, 1562, 10.2105/AJPH.90.10.1562
Wood, 2006, Summary of findings from the evaluation of a pilot medically supervised safer injecting facility, Canadian Medical Association Journal, 175, 1399, 10.1503/cmaj.060863
Wood, 2003, An external evaluation of a peer-run “unsanctioned” syringe exchange program, Journal of Urban Health, 80, 455, 10.1093/jurban/jtg052
Wood, 2005, Factors associated with syringe sharing among users of a medically supervised safer injecting facility, American Journal of Infectious Disease, 1, 50, 10.3844/ajidsp.2005.50.54
Wood, 2002, Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme, AIDS, 16, 941, 10.1097/00002030-200204120-00021
Wright, 2006, A review of the evidence for the effectiveness of primary prevention interventions for Hepatitis C among injecting drug users, Harm Reduction Journal, 6, 27, 10.1186/1477-7517-3-27